Effects of Endothelins on Cardiac and Vascular Cells: New Therapeutic Target for the Future?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|2|1|53-63

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.2, Iss.1, 2004-01, pp. : 53-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Insights into the Mechanisms Underlying Vascular and Cardiac Effects of Urocortin

By  

Current Vascular Pharmacology, Vol. 11, Iss. 4, 2013-07 ,pp. : 457-464

Bentham Science Publishers

Access to resources Recommend Favorite

Osteopontin: an emerging therapeutic target in uraemic vascular disease

By Zhang Xin   Eirin Alfonso   Lerman Amir   Lerman Lilach O.  

Cardiovascular Research, Vol. 98, Iss. 3, 2013-06 ,pp. : 332-333

Oxford University Press

Access to resources Recommend Favorite

Matrix Metalloproteinases in Vascular Disease - A Potential Therapeutic Target?

By  

Current Vascular Pharmacology, Vol. 8, Iss. 1, 2010-01 ,pp. : 75-85

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiac Remodeling as Therapeutic Target: Treating Heart Failure with Cardiac Support Devices

By Mann Douglas  

Heart Failure Reviews, Vol. 10, Iss. 2, 2005-06 ,pp. : 93-94

Springer Publishing Company

Access to resources Recommend Favorite

Editorial [Hot topic:Vascular Protective Effects of Ezetimibe: Seeking New Therapeutic Possibilities of Ezetimibe in Vascular Disease (Guest Editor: Minako Yamaoka-Tojo)]

By  

Current Vascular Pharmacology, Vol. 9, Iss. 1, 2011-01 ,pp. : 61-61

Bentham Science Publishers

Access to resources Recommend Favorite